Roche

Mycophenolate mofetil-cellcept

"Mycophenolate Mofetil" is the Drug / Molecule content in “Cellcept”. Cellcept belongs to class of dug- immunosuppressive (lowers body's immune system) which act by inhibiting an enzyme needed for the growth of T cells and B cells. Human body may "reject" an organ transplant when the immune system treats the new organ as an invader. An immunosuppressant helps to prevent this rejection.

Details
Specification

Indication

Cellcept is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate Mofetil also used in the treatment of autoimmune disease, such as behcet's disease, pemphigus vulgaris, systemic lupus erythematosus and refractory incomplete lupus erythematosus

Note

Precaution

Cellcept is a prescription drug and should be used under proper medical guidance and advice.
Increased risk of loss of a pregnancy (miscarriage) and higherrisk of birth defects.
Increased risk of getting serious infections.

Updated On Oct 19, 2019 by Admin